000 | 01958 a2200505 4500 | ||
---|---|---|---|
005 | 20250517090723.0 | ||
264 | 0 | _c20160817 | |
008 | 201608s 0 0 eng d | ||
022 | _a1872-8421 | ||
024 | 7 |
_a10.1016/j.jneuroim.2016.02.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTse, Kai-Hei | |
245 | 0 | 0 |
_aPGE2 released by primary sensory neurons modulates Toll-like receptor 4 activities through an EP4 receptor-dependent process. _h[electronic resource] |
260 |
_bJournal of neuroimmunology _cApr 2016 |
||
300 |
_a8-16 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCulture Media, Conditioned _xpharmacology |
650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinases _xmetabolism |
650 | 0 | 4 |
_aCyclooxygenase 2 _xgenetics |
650 | 0 | 4 |
_aDinoprostone _xmetabolism |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGanglia, Spinal _xcytology |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
650 | 0 | 4 |
_aLipopolysaccharide Receptors _xmetabolism |
650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aQuinolines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Prostaglandin E, EP4 Subtype _xantagonists & inhibitors |
650 | 0 | 4 |
_aSensory Receptor Cells _xdrug effects |
650 | 0 | 4 |
_aSulfonamides _xpharmacology |
650 | 0 | 4 |
_aThiophenes _xpharmacology |
650 | 0 | 4 |
_aToll-Like Receptor 4 _xmetabolism |
650 | 0 | 4 |
_aTriazoles _xpharmacology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
700 | 1 | _aChow, Kevin B S | |
700 | 1 | _aWise, Helen | |
773 | 0 |
_tJournal of neuroimmunology _gvol. 293 _gp. 8-16 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jneuroim.2016.02.005 _zAvailable from publisher's website |
999 |
_c25897654 _d25897654 |